AFAMOSI: Efficacy and Safety of Afatinib Followed by Osimertinib Compared to Osimertinib in Patients with EGFRmutated/T790M Mutation Negative Nonsquamous NSCLC
AFAMOSI: Efficacy and Safety of Afatinib Followed by Osimertinib Compared to Osimertinib in Patients with EGFRmutated/T790M Mutation Negative Nonsquamous NSCLC
Active, not recruiting · NCT04413201 · Registry updated 2025-03-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AFAMOSI: Efficacy and Safety of Afatinib Followed by Osimertinib Compared to Osimertinib in Patients with EGFRmutated/T790M Mutation Negative Nonsquamous NSCLC | Non-squamous NSCLC | Active, not recruiting | Phase 4 | 2025-03-25 | NCT04413201 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boehringer Ingelheim | 158 |
| Michael Hopp | 2 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Evangelische Lungenklinik Berlin | Berlin | Germany | 23 |
| Evangelisches Krankenhaus Hamm | Hamm | Germany | 2 |
| Gemeinnützige Krankenhausbetriebsgesellschaft Konstanz Mbh | Konstanz | Germany | 1 |
| Klinik Löwenstein gGmbH | Löwenstein | Germany | 1 |
| Klinikum Bremen-Ost | Bremen | Germany | 1 |
| Klinikum der Ludwig-Maximilians-Universität München | München | Germany | 1 |
| Klinikverbund Allgäug gGmbH, Klinik für Pneumologie, c/o Klinik | Immenstadt im Allgäu | Germany | 1 |
| Sana-Klinikum Offenbach | Offenbach | Germany | 2 |
| Studiengesellschaft Hämato-Onkologie Hamburg | Hamburg | Germany | 1 |
| Universitätsklinikum Gießen Marburg | Giessen | Germany | 2 |
| Universitätsklinikum Regensburg | Regensburg | Germany | 25 |